Global Foot and Mouth Disease (FMD) Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2019-2025

In 2018, the global Foot and Mouth Disease (FMD) Vaccines market size was increased to 791.90million US$ from 568.10 million US$ in 2014, and it will reach 1504.82 million US$ in 2025, growing at CAGR of 9.55% between 2019 and 2025.

This study researches the market size of Foot and Mouth Disease (FMD) Vaccines, presents the global Foot and Mouth Disease (FMD) Vaccines sales and revenue by companies, regions, type and application, history breakdown data from 2014 to 2019, and forecast to 2025.

This report focuses on the key data information of Foot and Mouth Disease (FMD) Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Foot and Mouth Disease (FMD) Vaccines for each region and countries in each region.

This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

This report includes the following manufacturers: (we can also add the other companies as you want)

• Jinyu Group
• Cavet Bio
• Indian Immunologicals
• Tecon Group
• CAHIC
• Shen Lian
• Biogenesis Bago
• BIGVET Biotech
• Boehringer Ingelheim
• MSD Animal Health
• CEVA
• FGBI
• Bayer HealthCare
• Brilliant Bio Pharma
• VECOL
• Sanofi (Merial)
• VETAL
• BVI
• LIMOR
• ME VAC
• Agrovet

Market Segment by Product Type

• 1 Emergency Vaccines
• 2 Conventional Vaccines

Market Segment by Application

• 1 Cattle
• 2 Pig
• 3 Sheep & Goat
• 4 Others

Key Regions split in this report:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Southeast Asia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Rest of Central & South America
• Middle East & Africa
• Saudi Arabia
• South Africa
• Egypt
• Rest of Middle East & Africa

Table of Contents

1 Report Overview 1

• 1.1 Research Scope 1
• 1.2 Major Manufacturers Covered in This Report 2
• 1.3 Market Segment by Type 3
  • 1.3.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size Growth Rate by Type 4
  • 1.3.2 Emergency Vaccines 6
  • 1.3.3 Conventional Vaccines 7
• 1.4 Market Segment by Application 7
  • 1.4.1 Global Foot and Mouth Disease (FMD) Vaccines Market Share by Application (2019-2025) 7
  • 1.4.2 Cattle 9
  • 1.4.3 Pig 9
  • 1.4.4 Sheep & Goat 10
• 1.5 Study Objectives 10
• 1.6 Years Considered 11

2 Global Growth Trends 12

• 2.1 Global Foot and Mouth Disease (FMD) Vaccines Market Size 12
  • 2.1.1 Global Foot and Mouth Disease (FMD) Vaccines Revenue 2014-2025 12
  • 2.1.2 Global Foot and Mouth Disease (FMD) Vaccines Sales 2014-2025 12
• 2.2 Foot and Mouth Disease (FMD) Vaccines Growth Rate by Regions 13
  • 2.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Regions 2014-2019 14
  • 2.2.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Regions 2014-2019 16
• 2.3 Industry Trends 17
  • 2.3.1 Market Top Trends 17
  • 2.3.2 Market Drivers 17
  • 2.3.3 Porter's Five Forces Analysis 18

3 Market Share by Manufacturers 19

• 3.1 Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers 19
  • 3.1.1 Foot and Mouth Disease (FMD) Vaccines Sales by Manufacturers 2018-2019 19
  • 3.1.2 Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Manufacturers 2018-2019 20
• 3.2 Revenue by Manufacturers 21
  • 3.2.1 Foot and Mouth Disease (FMD) Vaccines Revenue by Manufacturers (2018-2019) 21
  • 3.2.2 Foot and Mouth Disease (FMD) Vaccines Revenue Share by Manufacturers (2018-2019) 22
  • 3.2.3 Global Foot and Mouth Disease (FMD) Vaccines Market Concentration Ratio 24
• 3.3 Foot and Mouth Disease (FMD) Vaccines Price by Manufacturers 24
• 3.4 Key Manufacturers Foot and Mouth Disease (FMD) Vaccines Headquarters and Established Date 25
• 3.5 Mergers & Acquisitions, Expansion Plans 26

4 Market Size by Type 27

• 4.1 Sales and Revenue for Each Type 27
  • 4.1.1 Emergency Vaccines Sales and Revenue (2014-2019) 27
  • 4.1.2 Conventional Vaccines Sales and Revenue (2014-2019) 27
• 4.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Type 27
• 4.3 Global Foot and Mouth Disease (FMD) Vaccines Revenue Market Share by Type 29
• 4.4 Foot and Mouth Disease (FMD) Vaccines Price by Type 31

5 Market Size by Application 32

• 5.1 Overview 32
• 5.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Application 32

6 North America 34

• 6.1 North America Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Company 35
• 6.2 North America Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Type 35
• 6.3 North America Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Application 36
• 6.4 North America Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Countries 37
  • 6.4.1 North America Foot and Mouth Disease (FMD) Vaccines Sales by Countries 37
  • 6.4.2 North America Foot and Mouth Disease (FMD) Vaccines Revenue by Countries 39
  • 6.4.3 United States 40
  • 6.4.4 Canada 40
  • 6.4.5 Mexico 41

7 Europe 42

• 7.1 Europe Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Company 43
• 7.2 Europe Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Type 43
• 7.3 Europe Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Application 44
• 7.4 Europe Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Countries 45
  • 7.4.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales by Countries 45
  • 7.4.2 Europe Foot and Mouth Disease (FMD) Vaccines Revenue by Countries 47
  • 7.4.3 Germany 48
  • 7.4.4 France 49
  • 7.4.5 UK 49
  • 7.4.6 Italy 50
  • 7.4.7 Russia 50

8 Asia Pacific 51

• 8.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Company 52
• 8.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Type 53
• 8.3 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Application 54
• 8.4 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Countries 55
  • 8.4.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales by Countries 55
  • 8.4.2 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Revenue by Countries 56
  • 8.4.3 China 57
  • 8.4.4 Japan 58
  • 8.4.5 Korea 59
  • 8.4.6 India 60
  • 8.4.7 Southeast Asia 61

9 Central & South America 63

• 9.1 Central & South America Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Company 64
• 9.2 Central & South America Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Type 65
• 9.3 Central & South America Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Application 66
• 9.4 Central & South America Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Countries 67
  • 9.4.1 Central & South America Foot and Mouth Disease (FMD) Vaccines Sales by Countries 67
  • 9.4.2 Central & South America Foot and Mouth Disease (FMD) Vaccines Revenue by Countries 68
  • 9.4.3 Brazil 70

10 Middle East and Africa 71

• 10.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Type 72
• 10.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Application 73
• 10.3 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Breakdown Data by Countries 74
  • 10.3.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales by Countries 74
  • 10.3.2 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Revenue by Countries 75
  • 10.3.3 Saudi Arabia 76
  • 10.3.4 Egypt 77
  • 10.3.5 South Africa 78

11 Analysis of Foot and Mouth Disease (FMD) Vaccines Industry Key Manufacturers 80

• 11.1 Jinyu Group 80
  • 11.1.1 Company Profile 80
  • 11.1.2 Product Information 81
  • 11.1.3 Capacity, Sales, Price, Cost, Gross, and Revenue 81
• 11.2 Cavet Bio 82
  • 11.2.1 Company Profile 82
  • 11.2.2 Product Information 83
  • 11.2.3 Capacity, Sales, Price, Cost, Gross, and Revenue 83
• 11.3 Indian Immunologicals 84
  • 11.3.1 Company Profile 84
  • 11.3.2 Product Information 85
  • 11.3.3 Capacity, Sales, Price, Cost, Gross, and Revenue 85
• 11.4 Tecon Group 86
  • 11.4.1 Company Profile 86
  • 11.4.2 Product Information 87
  • 11.4.3 Capacity, Sales, Price, Cost, Gross, and Revenue 87
• 11.5 CAHIC 88
  • 11.5.1 Company Profile 88
  • 11.5.2 Product Information 89
  • 11.5.3 Capacity, Sales, Price, Cost, Gross, and Revenue 89
• 11.6 Shen Lian 89
  • 11.6.1 Company Profile 89
  • 11.6.2 Product Information 91
  • 11.6.3 Capacity, Sales, Price, Cost, Gross, and Revenue 91
• 11.7 Biogenesis Bago 92
  • 11.7.1 Company Profile 92
  • 11.7.2 Product Information 93
  • 11.7.3 Capacity, Sales, Price, Cost, Gross, and Revenue 93
• 11.8 BIGVET Biotech 94
  • 11.8.1 Company Profile 94
  • 11.8.2 Product Information 95
  • 11.8.3 Capacity, Sales, Price, Cost, Gross, and Revenue 95
• 11.9 Boehringer Ingelheim 96
  • 11.9.1 Company Profile 96
  • 11.9.2 Product Information 97
  • 11.9.3 Capacity, Sales, Price, Cost, Gross, and Revenue 97
• 11.10 MSD Animal Health 98
  • 11.10.1 Company Profile 98
  • 11.10.2 Product Information 99
  • 11.10.3 Capacity, Sales, Price, Cost, Gross, and Revenue 100
• 11.11 CEVA 100
  • 11.11.1 Company Profile 100
  • 11.11.2 Product Information 101
  • 11.11.3 Capacity, Sales, Price, Cost, Gross, and Revenue 102
• 11.12 FGBI 102
  • 11.12.1 Company Profile 102
  • 11.12.2 Product Information 103
  • 11.12.3 Capacity, Sales, Price, Cost, Gross, and Revenue 104
• 11.13 Bayer HealthCare 104
  • 11.13.1 Company Profile 104
  • 11.13.2 Product Information 105
  • 11.13.3 Capacity, Sales, Price, Cost, Gross, and Revenue 105
• 11.14 Brilliant Bio Pharma 106
  • 11.14.1 Company Profile 106
  • 11.14.2 Product Information 107
  • 11.14.3 Capacity, Sales, Price, Cost, Gross, and Revenue 107
• 11.15 VECOL 108
  • 11.15.1 Company Profile 108
  • 11.15.2 Product Information 109
  • 11.15.3 Capacity, Sales, Price, Cost, Gross, and Revenue 109
• 11.16 Sanofi (Merial) 110
  • 11.16.1 Company Profile 110
  • 11.16.2 Product Information 111
  • 11.16.3 Capacity, Sales, Price, Cost, Gross, and Revenue 111
• 11.17 VETAL 112
  • 11.117.1 Company Profile 112
  • 11.17.2 Product Information 113
  • 11.17.3 Capacity, Sales, Price, Cost, Gross, and Revenue 113
• 11.18 BVI 113
  • 11.18.1 Company Profile 113
  • 11.18.2 Product Information 114
  • 11.18.3 Capacity, Sales, Price, Cost, Gross, and Revenue 115
• 11.19 LIMOR 115
  • 11.19.1 Company Profile 115
  • 11.19.2 Product Information 116
  • 11.19.3 Capacity, Sales, Price, Cost, Gross, and Revenue 116
• 11.20 ME VAC 117
  • 11.20.1 Company Profile 117
  • 11.20.2 Product Information 118
  • 11.20.3 Capacity, Sales, Price, Cost, Gross, and Revenue 118
• 11.21 Agrovet 118
  • 11.21.1 Company Profile 118
  • 11.21.2 Product Information 119
  • 11.21.3 Capacity, Sales, Price, Cost, Gross, and Revenue 120
• 11.22 Pokrov Biologics Plant 120
• 11.23 FGUP Schelkovsky Biofactory 121

12 Value Chain and Sales Channels Analysis 122

• 12.1 Value Chain Analysis 122
• 12.2 Sales Channels Analysis 123
  • 12.2.1 Foot and Mouth Disease (FMD) Vaccines Sales Channels 123
  • 12.2.2 Foot and Mouth Disease (FMD) Vaccines Distributors 125
• 12.3 Foot and Mouth Disease (FMD) Vaccines Customers 127

13 Market Forecast 129

• 13.1 Global Foot and Mouth Disease (FMD) Vaccines Sales and Revenue Forecast 2019-2025 129
• 13.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Type 130
• 13.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Application 131
• 13.4 Foot and Mouth Disease (FMD) Vaccines Forecast by Regions 132
  • 13.4.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Regions2019-2025 132
  • 13.4.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue Forecast by Regions2019-2025 133
• 13.5 North America Market Forecast 134
  • 13.5.1 North America Foot and Mouth Disease (FMD) Vaccines Forecast by Countries 2019-2025 134
  • 13.5.2 United States 135
  • 13.5.3 Canada 136
  • 13.5.4 Mexico 136
• 13.6 Europe Market Forecast 137
  • 13.6.1 Europe Foot and Mouth Disease (FMD) Vaccines Forecast by Countries 2019-2025 137
  • 13.6.2 Germany 138
  • 13.6.3 France 139
  • 13.6.4 UK 139
  • 13.6.5 Italy 140
  • 13.6.6 Russia 140
• 13.7 Asia Pacific Market Forecast 141
  • 13.7.1 Asia Pacific Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Countries 2019-2025 141
  • 13.7.2 China 142
  • 13.7.3 Japan 143
  • 13.7.4 Korea 143
  • 13.7.5 India 144
  • 13.7.6 Southeast Asia 144
• 13.8 Central & South America Market Forecast 145
  • 13.8.1 Central & South America Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Countries 2019-2025 145
  • 13.8.2 Brazil 146
• 13.9 Middle East and Africa Market Forecast 147
  • 13.9.1 Middle East and Africa Foot and Mouth Disease (FMD) Vaccines Sales Forecast by Regions 2019-2025 147
  • 13.9.2 Saudi Arabia 148
  • 13.9.3 Egypt 149
  • 13.9.4 South Africa 149

14 Research Findings and Conclusion 150

15 Appendix 151

• 15.1 Research Methodology 151
  • 15.1.1 Methodology/Research Approach 151
  • 15.1.2 Data Source 155
• 15.2 Author Details 157
• 15.3 Disclaimer 157